homovanillic acid has been researched along with Cerebrovascular Disorders in 11 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "For understanding of the role of monoamines in cerebral ischemia, 3-methoxy-4-hydroxyphenylglycol (MHPG), hydroxyindoleacetic acid (5HIAA) homovanillic acid (HVA) the three major monoamine metabolites in CSF of 33 patients and 18 controls were measured with high-performance liquid chromatography." | 3.68 | [The changes of monoamine metabolites in CSF of patients with cerebral stroke]. ( Tang, HZ, 1991) |
| "The concentrations of homovanillic acid (HVA), 3-methoxy, 4-hydroxyphenylglycol (MHPG), and 5-hydroxyindolylacetic acid (5-HIAA) were measured in samples of ventricular cerebrospinal fluid (CSF) taken from 15 patients who were comatose as a result of an acute head injury, a tumour, or a cerebrovascular accident." | 3.66 | Amine metabolites in ventricular cerebrospinal fluid in coma. ( Tsementzis, SA; Wilson, H; Yates, CM, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (72.73) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herbert, MK | 1 |
| Kuiperij, H | 1 |
| Bloem, BR | 1 |
| Verbeek, MM | 1 |
| Becker, RE | 1 |
| Lal, H | 1 |
| Jellinger, K | 1 |
| Riederer, P | 1 |
| Togashi, H | 1 |
| Matsumoto, M | 1 |
| Yoshioka, M | 1 |
| Hirokami, M | 1 |
| Minami, M | 1 |
| Saito, H | 1 |
| Moskowitz, MA | 1 |
| Wurtman, RJ | 1 |
| Yates, CM | 1 |
| Tsementzis, SA | 1 |
| Wilson, H | 1 |
| Tang, HZ | 1 |
| Kawakami, M | 1 |
| Itoh, T | 1 |
| Minegishi, A | 1 |
| Ishizaki, T | 1 |
| Yoshida, Y | 1 |
| Ahagon, A | 1 |
| Shibata, N | 1 |
| Kobayashi, H | 1 |
| Lamers, KJ | 1 |
| Schoonderwaldt, HC | 1 |
| Borkent, MV | 1 |
| Theeuwes, AG | 1 |
| Doesburg, WH | 1 |
| Wevers, RA | 1 |
| Johannsson, B | 1 |
| Roos, BE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers[NCT01086696] | Early Phase 1 | 6 participants (Actual) | Interventional | 2010-03-09 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for homovanillic acid and Cerebrovascular Disorders
| Article | Year |
|---|---|
Pharmacological approaches to treatment of hemiballism and hemichorea.
Topics: Acetylcholine; Antipsychotic Agents; Basal Ganglia; Cerebrovascular Disorders; Chorea; Diazepam; Dop | 1983 |
Catecholamines and neurologic diseases (second of two parts).
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Brain; Brain Diseases; Catecholamines; Cereb | 1975 |
9 other studies available for homovanillic acid and Cerebrovascular Disorders
| Article | Year |
|---|---|
Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controls.
Topics: Aged; Cerebrovascular Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; | 2013 |
[Central neurotransmitters in cerebral ischemia and stroke].
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Cerebral Infarction; Cerebrovascular Diso | 1983 |
Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Biogenic Monoamines; Blood Pressure; Cerebro | 1994 |
Amine metabolites in ventricular cerebrospinal fluid in coma.
Topics: Adolescent; Adult; Brain Injuries; Brain Neoplasms; Cerebrospinal Fluid Proteins; Cerebrovascular Di | 1979 |
[The changes of monoamine metabolites in CSF of patients with cerebral stroke].
Topics: Brain Ischemia; Cerebrovascular Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Ac | 1991 |
[Effects of idebenone on monoamine metabolites in the cerebrospinal fluid of patients with cerebrovascular dementia].
Topics: Aged; Benzoquinones; Biogenic Amines; Cerebrovascular Disorders; Chromatography, High Pressure Liqui | 1986 |
Plasma monoaminergic metabolites and catecholamines in subarachnoid hemorrhage. Clinical implications.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Catecholamines; Cerebrovascular Disorders; Dopamine; Ep | 1987 |
The effects of acute cerebrovascular disease on serum and cerebrospinal fluid parameters.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspartate Aminotransferases; Cerebrospinal Fluid Prot | 1987 |
5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases.
Topics: Adult; Brain Neoplasms; Central Nervous System Diseases; Cerebellar Ataxia; Cerebrovascular Disorder | 1974 |